CC-486 (oral azacitidine)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CC-486 (oral azacitidine), covering 2017-03-24 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma [Phase 2, Phase 3]